Ofatumumab Intravenous and Zuplenz

• Generic Name: ofatumumab
• Dosage Forms: n.a.
• Other Brand Names: Arzerra

Ofatumumab injection is used in combination with chlorambucil to treat a type of cancer of the white blood cells called chronic lymphocytic leukemia (CLL) in patients who have not received any treatments in the past. It is also used in combination with fludarabine and cyclophosphamide to treat patients with relapsed CLL. Ofatumumab is also used in patients with CLL who have already been treated with other medicines (eg, alemtuzumab, fludarabine) that did not work well.

Ofatumumab interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by ofatumumab, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Some unwanted effects, such as a skin rash, may not be serious but may cause concern. Some of the unwanted effects do not occur until months or years after the medicine is used.

Before you begin treatment with ofatumumab, you and your doctor should talk about the benefits ofatumumab will do as well as the risks of using it.

Ofatumumab is to be given only by or under the direct supervision of your doctor.

• Generic Name: ondansetron
• Dosage Forms: film, soluble
• Other Brand Names: Zofran, Zofran ODT, Zuplenz

Zuplenz (ondansetron) blocks the actions of chemicals in the body that can trigger nausea and vomiting.

Zuplenz is used to prevent nausea and vomiting that may be caused by surgery, cancer chemotherapy, or radiation treatment.

Zuplenz may be used for purposes not listed in this medication guide.